AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2026
Feb 6, 2026
32093_dirs_2026-02-06_730d72e5-a17f-4758-aadf-e08380ea4d8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2026-01-08
Reporting Person: Sainz Maria (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | Stock Option (right to buy) | $14.72 | A | 50000 | Acquired | 2036-01-08 | Common Stock (50000) | Direct |
| 2026-02-05 | Stock Option (right to buy) | $13.69 | A | 3104 | Acquired | 2036-02-05 | Common Stock (3104) | Direct |
Footnotes
F1: One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date.
F2: The shares subject to the option will vest in equal installments on March 5, 2026 and June 5, 2026, subject to the Reporting Person's continued service through each vesting date.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17